Install
Please confirm you are human
This browser or connection looks automated. Press and continuously hold the control for 3 seconds to enable Google-hosted web results and, when separately allowed, AI-assisted answers.
A successful check enables 100 search requests. Interactive access does not authorize scraping, systematic collection, or reuse of search output.
News
Capricor Deadline: CAPR Investors Have Opportunity to Lead Capricor Therapeutics, Inc. Securities Fraud Lawsuit
13+ hour, 26+ min ago (217+ words) Morningstar Capricor Deadline: CAPR Investors Have Opportunity to Lead Capricor Therapeutics, Inc Securities Fraud LawsuitPR NewswireNEW YORK, Sept 13, 2026NEW YORK, Sept 13, 2026 /PRNewswire/ -- Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Capricor Therapeutics, Inc (NASDAQ: CAPR)…...
AI Training for Marketing Teams | OneRange Vero Catalog
1+ day, 3+ hour ago (328+ words) Vero AI Catalog › AI for marketing teams Every course here is delivered by OneRange Vero as an interactive session. There is no video to sit through and no slide deck to click past: the tutor explains an idea, works an…...
48-HOUR REGN INVESTOR DEADLINE: Regeneron Pharmaceuticals, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
1+ day, 18+ hour ago (296+ words) September 12, 2026 4:00 PM EDT | Source: Robbins Geller Rudman & Dowd LLP If you suffered substantial losses and wish to serve as lead plaintiff of the Regeneron class action lawsuit, please provide your information here: You can also contact attorneys Ken Dolitsky or…...
Over 15 biotech companies accused of manipulating antibody images
5+ day, 5+ hour ago (744+ words) A recent scientific report found almost 19,000 doctored images of antibodies available in the commercial market. A landmark investigation published by Northwestern University’s Reese Richardson found widespread image manipulation in the commercial antibody market. In the online article, more than 15 well-known…...
Greenberg Traurig Sued Over Ex-Pharma CEO's Indictment - Law360 Pulse
3+ day, 17+ hour ago (85+ words) Greenberg Traurig Sued Over Ex-Pharma CEO's Indictment Law360 Try our Advanced Search for more refined results Law360 | The Practice of Law Law360 Authority | Deep News & Analysis Law360 Pulse | The Business of Law Greenberg Traurig Sued Over Ex-Pharma CEO's Indictment By George Woolston · September 10, 2026, 4:52 PM…...
Greenberg Traurig Sued Over Ex-Pharma CEO's Indictment - Law360 Healthcare Authority
3+ day, 17+ hour ago (69+ words) Greenberg Traurig Sued Over Ex-Pharma CEO's Indictment Law360 Law360 | The Practice of Law Law360 Authority | Deep News & Analysis Law360 Pulse | The Business of Law Greenberg Traurig Sued Over Ex-Pharma CEO's Indictment By George Woolston · September 10, 2026, 4:52 PM EDT Recent Articles By George Get instant access…...
AARD Shareholder Alert: Aardvark Therapeutics, Inc. Securities Class Action Lawsuit - Investors With Losses May Contact SueWallSt
3+ day, 18+ hour ago (572+ words) NEW YORK, Sept. 10, 2026 Sections 11 and 15 of the Securities Act impose liability for registration statements containing untrue statements of material fact. A securities class action alleges Aardvark Therapeutics' IPO paperwork described ARD-101 as "99% restricted to the gut" with "no serious adverse…...
CAPR INVESTOR DEADLINE: Capricor Therapeutics, Inc. Investors with Substantial Losses Have Opportunity to Lead Shareholder Class Action Lawsuit Before September 28 Deadline
4+ day, 17+ hour ago (330+ words) Sep 09, 2026, 17:02 ET Hagens Berman encourages investors in Capricor Therapeutics, Inc. (NASDAQ: CAPR) who suffered substantial losses to submit your losses now. FDA Extends BLA Review Following Post-AdCom Submissions On Aug. 24, Capricor announced that the FDA has extended the Prescription Drug…...
Meet The Attorneys Guiding BioXcel Therapeutics' Ch.11 - Law360 Healthcare Authority
5+ day, 13+ hour ago (80+ words) Meet The Attorneys Guiding BioXcel Therapeutics' Ch.11 Law360 Law360 | The Practice of Law Law360 Authority | Deep News & Analysis Law360 Pulse | The Business of Law Meet The Attorneys Guiding BioXcel Therapeutics' Ch.11 By Yun Park · September 8, 2026, 9:00 PM EDT /healthcare-authority/tracked_cases?case_id=6a917a84d3efe34cc925fd08&case_title=BioXcel+Therapeutics%2C+Inc. BioXcel Therapeutics, Inc....
UNCY Investors Have Opportunity to Lead Unicycive Therapeutics, Inc. Securities Fraud Lawsuit
5+ day, 14+ hour ago (207+ words) Morningstar UNCY Investors Have Opportunity to Lead Unicycive Therapeutics, Inc Securities Fraud Lawsuit PR Newswire NEW YORK, Sept 8, 2026 NEW YORK, Sept 8, 2026 /PRNewswire/ -- Why: Rosen Law Firm, a global investor rights law firm, announces a class action lawsuit on behalf of…...